Role of cpxA Mutations in the Resistance to Aminoglycosides and β-Lactams in Salmonella enterica serovar Typhimurium. 2021

Wenxian Jing, and Juan Liu, and Shanshan Wu, and Xuerui Li, and Yongsheng Liu
State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.

Although it has been reported that deletion of the response regulator, CpxR, in the CpxRA system confers sensitivity to aminoglycosides (AGAs) and β-lactams in Salmonella enterica serovar Typhimurium, the regulatory effects of CpxA on multidrug resistance (MDR) are yet to be fully investigated in this organism. Here, to explore the role of CpxA in MDR, various cpxA mutants including a null mutant (JSΔcpxA), a site-directed mutant (JSΔcpxA 38) and an internal in-frame deletion mutant (JSΔcpxA ) of the S. enterica serovar Typhimurium strain JS, were constructed. It was revealed that cpxA and cpxR deletion mutants have opposing roles in the regulation of resistance to AGAs and β-lactams. Amikacin and cefuroxime can activate the CpxRA system, which results in increased resistance of the wild-type compared with the cpxR deletion mutant. All the cpxA mutations significantly increased resistance to AGAs and β-lactams due to CpxRA system activation via the phosphorylation of CpxR. Moreover, AckA-Pta-dependent activation of CpxR increased the antibiotic resistance of cpxA deletion mutants. Further research revealed that the AcrAB-TolC conferred resistance to some AGAs and β-lactams but does not influence the regulation of resistance by CpxRA against these antibiotics. The detection of candidate MDR-related CpxR regulons revealed that the mRNA expression levels of spy, ycca, ppia, htpX, stm3031, and acrD were upregulated and that of ompW was downregulated in various cpxA mutants. Furthermore, the expression levels of nuoA and sdhC mRNAs were downregulated only in JSΔcpxA . These results suggested that cpxA mutations contribute to AGAs and β-lactams resistance, which is dependent on CpxR.

UI MeSH Term Description Entries

Related Publications

Wenxian Jing, and Juan Liu, and Shanshan Wu, and Xuerui Li, and Yongsheng Liu
January 2016, Frontiers in microbiology,
Wenxian Jing, and Juan Liu, and Shanshan Wu, and Xuerui Li, and Yongsheng Liu
July 2008, The Journal of antimicrobial chemotherapy,
Wenxian Jing, and Juan Liu, and Shanshan Wu, and Xuerui Li, and Yongsheng Liu
August 2018, Journal of bacteriology,
Wenxian Jing, and Juan Liu, and Shanshan Wu, and Xuerui Li, and Yongsheng Liu
July 2008, Antimicrobial agents and chemotherapy,
Wenxian Jing, and Juan Liu, and Shanshan Wu, and Xuerui Li, and Yongsheng Liu
January 2000, Emerging infectious diseases,
Wenxian Jing, and Juan Liu, and Shanshan Wu, and Xuerui Li, and Yongsheng Liu
August 2006, Journal of bacteriology,
Wenxian Jing, and Juan Liu, and Shanshan Wu, and Xuerui Li, and Yongsheng Liu
January 2013, Frontiers in microbiology,
Wenxian Jing, and Juan Liu, and Shanshan Wu, and Xuerui Li, and Yongsheng Liu
April 2009, Emerging infectious diseases,
Wenxian Jing, and Juan Liu, and Shanshan Wu, and Xuerui Li, and Yongsheng Liu
July 2008, The Journal of antimicrobial chemotherapy,
Wenxian Jing, and Juan Liu, and Shanshan Wu, and Xuerui Li, and Yongsheng Liu
January 2017, Frontiers in microbiology,
Copied contents to your clipboard!